Table 6.
Category | Item | Count | P-value |
---|---|---|---|
GO-BP | axonogenesis | 46 | < 0.001 |
GO-BP | axon development | 48 | < 0.001 |
GO-BP | Ras protein signal transduction | 45 | < 0.001 |
GO-BP | eye development | 37 | < 0.001 |
GO-BP | mesenchyme development | 30 | < 0.001 |
GO-CC | cell leading edge | 37 | < 0.001 |
GO-CC | actin cytoskeleton | 40 | 0.002 |
GO-CC | cortical cytoskeleton | 15 | 0.002 |
GO-CC | lamellipodium | 21 | 0.002 |
GO-CC | cell cortex | 28 | 0.002 |
GO-MF | transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | 41 | < 0.001 |
GO-MF | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding | 38 | < 0.001 |
GO-MF | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding | 28 | < 0.001 |
GO-MF | proximal promoter sequence-specific DNA binding | 37 | < 0.001 |
GO-MF | nucleoside-triphosphatase regulator activity | 31 | < 0.001 |
KEGG | Axon guidance | 21 | < 0.001 |
KEGG | Melanogenesis | 15 | < 0.001 |
KEGG | Longevity regulating pathway - multiple species | 11 | < 0.001 |
KEGG | Parathyroid hormone synthesis, secretion and action | 14 | < 0.001 |
KEGG | Glutamatergic synapse | 14 | < 0.001 |
Note: BP: biological process; CC: cellular component; MF: molecular function